AU542834B2 - Creación de Inventos y Patentes con Inteligencia Artificial

AU542834B2 – Anti-invasion factor containing cultures
– Google Patents

AU542834B2 – Anti-invasion factor containing cultures
– Google Patents
Anti-invasion factor containing cultures

Info

Publication number
AU542834B2

AU542834B2
AU71717/81A
AU7171781A
AU542834B2
AU 542834 B2
AU542834 B2
AU 542834B2
AU 71717/81 A
AU71717/81 A
AU 71717/81A
AU 7171781 A
AU7171781 A
AU 7171781A
AU 542834 B2
AU542834 B2
AU 542834B2
Authority
AU
Australia
Prior art keywords
factor containing
containing cultures
invasion factor
invasion
cultures
Prior art date
1980-04-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Ceased

Application number
AU71717/81A
Other versions

AU7171781A
(en

Inventor
K.E. Kuettner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Rush Presbyterian St Lukes Medical Center

Original Assignee
Rush Presbyterian St Lukes Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1980-04-22
Filing date
1981-04-20
Publication date
1985-03-14

1981-04-20
Application filed by Rush Presbyterian St Lukes Medical Center
filed
Critical
Rush Presbyterian St Lukes Medical Center

1981-11-10
Publication of AU7171781A
publication
Critical
patent/AU7171781A/en

1985-03-14
Application granted
granted
Critical

1985-03-14
Publication of AU542834B2
publication
Critical
patent/AU542834B2/en

2001-04-20
Anticipated expiration
legal-status
Critical

Status
Ceased
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA

C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

C12N5/06—Animal cells or tissues; Human cells or tissues

C12N5/0602—Vertebrate cells

C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme

C12N5/0655—Chondrocytes; Cartilage

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES

A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses

A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix

A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA

C12N2500/00—Specific components of cell culture medium

C12N2500/30—Organic components

C12N2500/38—Vitamins

AU71717/81A
1980-04-22
1981-04-20
Anti-invasion factor containing cultures

Ceased

AU542834B2
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

US142731

1980-04-22

US06/142,731

US4356261A
(en)

1980-04-22
1980-04-22
Anti-invasion factor containing cultures

Publications (2)

Publication Number
Publication Date

AU7171781A

AU7171781A
(en)

1981-11-10

AU542834B2
true

AU542834B2
(en)

1985-03-14

Family
ID=22501054
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU71717/81A
Ceased

AU542834B2
(en)

1980-04-22
1981-04-20
Anti-invasion factor containing cultures

Country Status (6)

Country
Link

US
(1)

US4356261A
(en)

EP
(1)

EP0038719A3
(en)

JP
(1)

JPS57500541A
(en)

AU
(1)

AU542834B2
(en)

CA
(1)

CA1154697A
(en)

WO
(1)

WO1981003031A1
(en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

DE3686927T2
(en)

1985-02-26
1993-03-25
Univ Johns Hopkins

NEOVASCULARIZATION INHIBITORS AND THEIR PRODUCTION.

US4746729A
(en)

1986-07-30
1988-05-24
Kuettner Klaus E
Cartilage-derived leukocyte elastase-inhibitor

US5041138A
(en)

1986-11-20
1991-08-20
Massachusetts Institute Of Technology
Neomorphogenesis of cartilage in vivo from cell culture

US6309635B1
(en)

1986-11-20
2001-10-30
Children’s Medical Center Corp.
Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo

US5736372A
(en)

1986-11-20
1998-04-07
Massachusetts Institute Of Technology
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure

US5759830A
(en)

1986-11-20
1998-06-02
Massachusetts Institute Of Technology
Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo

US4846835A
(en)

1987-06-15
1989-07-11
Grande Daniel A
Technique for healing lesions in cartilage

US5242692A
(en)

1990-07-10
1993-09-07
Bar Ilan University
Anti-metastatic factor

US5284830A
(en)

1991-02-13
1994-02-08
The Board Of Trustees Of The Leland Stanford Junior University
Thyroid-derived chondrocyte-stimulating factor

US5326357A
(en)

1992-03-18
1994-07-05
Mount Sinai Hospital Corporation
Reconstituted cartridge tissue

WO1995003036A1
(en)

1993-07-19
1995-02-02
Angiogenesis Technologies, Inc.
Anti-angiogenic compositions and methods of use

US6025334A
(en)

1994-04-28
2000-02-15
Les Laboratoires Aeterna Inc.
Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof

US6028118A
(en)

1996-08-08
2000-02-22
Les Laboratoires Aeterna Inc.
Methods of using extracts of shark cartilage

US6380366B1
(en)

1994-04-28
2002-04-30
Les Laboratoires Aeterna Inc.
Shark cartilage extract:process of making, methods of using and compositions thereof

US5618925A
(en)

1994-04-28
1997-04-08
Les Laboratories Aeterna Inc.
Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof

US5723331A
(en)

1994-05-05
1998-03-03
Genzyme Corporation
Methods and compositions for the repair of articular cartilage defects in mammals

GB2296017A
(en)

1994-12-13
1996-06-19
Bradley Michael John Stringer
Chondrocyte cell-lines

US5716404A
(en)

1994-12-16
1998-02-10
Massachusetts Institute Of Technology
Breast tissue engineering

US6123727A
(en)

1995-05-01
2000-09-26
Massachusetts Institute Of Technology
Tissue engineered tendons and ligaments

US5855610A
(en)

1995-05-19
1999-01-05
Children’s Medical Center Corporation
Engineering of strong, pliable tissues

US5741685A
(en)

1995-06-07
1998-04-21
Children’s Medical Center Corporation
Parenchymal cells packaged in immunoprotective tissue for implantation

US6129761A
(en)

1995-06-07
2000-10-10
Reprogenesis, Inc.
Injectable hydrogel compositions

DE69637619D1
(en)

1995-11-06
2008-09-11
Mount Sinai Hospital Corp

RECONSTITUTED MINERALIZED CARTILAGE TISSUE

US20020111695A1
(en)

1995-11-06
2002-08-15
Mount Sinai Hospital Corporation
Reconstituted mineralized cartilage tissue

IL131701A
(en)

1997-03-11
2005-03-20
Aeterna Zentaris Inc
Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents

US6168807B1
(en)

1998-07-23
2001-01-02
Les Laboratoires Aeterna Inc.
Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof

US6197061B1
(en)

1999-03-01
2001-03-06
Koichi Masuda
In vitro production of transplantable cartilage tissue cohesive cartilage produced thereby, and method for the surgical repair of cartilage damage

AU2001256143A1
(en)

2000-05-01
2001-11-12
Medico-Kemisk Laboratorium
Chondrocyte cultures and fractions therefrom

AU2001286586A1
(en)

2000-08-18
2002-03-04
University Of Massachusetts Medical Center
Trance regulation of chondrocyte differentiation

JP2005506860A
(en)

2001-09-15
2005-03-10
ラツシユ−プレスビテリアン−セント・リユークズ・メデイカル・センター

Layered cartilage tissue and engineering method thereof

US20030165473A1
(en)

2001-11-09
2003-09-04
Rush-Presbyterian-St. Luke’s Medical Center
Engineered intervertebral disc tissue

US20030138873A1
(en)

2002-01-22
2003-07-24
Koichi Masuda
Tissue engineered cartilage for drug discovery

US7273756B2
(en)

2004-10-01
2007-09-25
Isto Technologies, Inc.
Method for chondrocyte expansion with phenotype retention

US8017394B2
(en)

2004-10-01
2011-09-13
Isto Technologies, Inc.
Method for chondrocyte expansion with phenotype retention

EP1764117A1
(en)

2005-09-20
2007-03-21
Zimmer GmbH
Implant for the repair of a cartilage defect and method for manufacturing the implant

US20150265325A1
(en)

2014-03-24
2015-09-24
Robert G Matheny
Sternal Closure Apparatus, System and Method

US9381218B2
(en)

2014-03-24
2016-07-05
Cermatrix Cardiovascular, Inc.
Artificial skeletal material and constructs formed therefrom

Family Cites Families (3)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US3450598A
(en)

1965-08-24
1969-06-17
Flow Lab
Method for cell propagation

USRE30239E
(en)

1975-11-10
1980-03-25

Cell proliferation and tissue invasion inhibitor

US4176177A
(en)

1978-11-16
1979-11-27
Rush-Presbyterian-St. Luke’s Medical Center
Inhibition of bone resorption

1980

1980-04-22
US
US06/142,731
patent/US4356261A/en
not_active
Expired – Lifetime

1981

1981-04-20
WO
PCT/US1981/000511
patent/WO1981003031A1/en
unknown

1981-04-20
AU
AU71717/81A
patent/AU542834B2/en
not_active
Ceased

1981-04-20
JP
JP56501643A
patent/JPS57500541A/ja
active
Pending

1981-04-22
CA
CA000375923A
patent/CA1154697A/en
not_active
Expired

1981-04-22
EP
EP81301773A
patent/EP0038719A3/en
not_active
Withdrawn

Also Published As

Publication number
Publication date

US4356261A
(en)

1982-10-26

CA1154697A
(en)

1983-10-04

AU7171781A
(en)

1981-11-10

EP0038719A3
(en)

1982-08-04

JPS57500541A
(en)

1982-04-01

WO1981003031A1
(en)

1981-10-29

EP0038719A2
(en)

1981-10-28

Información de contacto